Moderna (MRNA) Announces Phase 1/2 Data on mRNA-3927
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Moderna (MRNA) Q1 earnings, revenue surprisingly tops consensus estimates
May 4, 2023 9:50 AM EDTModerna (NASDAQ: MRNA) shares opened higher Thursday on the back of its surprising earnings and revenue beat.
The drugmaker had been expected to post a $1.75 loss in the quarter, however, it reported Q1 EPS of $0.19, topping expectations by $1.94. In addition, revenue... More
